Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model

Keyphrases

• Blood Flow 100%
• Mouse Model 100%
• Endothelial Cells 100%
• Diabetic 100%
• Diabetic Patients 100%
• High Glucose 100%
• Angiogenic Peptides 100%
• Diabetic Mouse Model 100%
• Ischemic Vascular Disease 100%
• Capillary Growth 100%
• Apoptosis 50%
• Hypoxia 50%
• Revascularization 50%
• After Surgery 50%
• Neovascularization 50%
• Clinical Observation 50%
• Histological Sections 50%
• Hindlimb Ischemia 50%
• Collateral Vessels 50%
• Streptozotocin 50%
• Anti-apoptosis 50%
• Proliferation Apoptosis 50%
• Blood Perfusion 50%
• Diabetic Mice 50%
• Vessel Development 50%
• Flow Restoration 50%
• Peptide Drugs 50%
• Capillary Density 50%
• Therapeutic Angiogenesis 50%
• Laser Doppler Imager 50%
• Mechanism Study 50%

Biochemistry, Genetics and Molecular Biology

• Mouse Model 100%
• Blood Flow 100%
• Capillary Proliferation 100%
• Mouse 66%
• Angiogenesis 33%
• Tissue Section 33%
• Perfusion 33%
• Neovascularization (Pathology) 33%
• Streptozotocin 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetes Mellitus 100%
• Mouse Model 100%
• Mouse 66%
• Vascular Disease 66%
• Hypoxia 33%
• Neovascularization (Pathology) 33%
• Streptozotocin 33%
• Limb Ischemia 33%